I. C. Alard

Type 2 17-β hydroxysteroid dehydrogenase as a novel target for the treatment of osteoporosis.

Jalal Soubhye, P. Van Antwerpen, F. Dufrasne, 2015, Future medicinal chemistry.

Novel bis-arylalkylamines as myeloperoxidase inhibitors: Design, synthesis, and structure-activity relationship study.

C. Obinger, M. Prévost, B. Elfving, 2016, European journal of medicinal chemistry.

Triple-stimuli responsive polymers with fine tuneable magnetic responses

K. Amighi, Jalal Soubhye, M. Gelbcke, 2017 .

Antioxidant effects and bioavailability evaluation of propolis extract and its content of pure polyphenols

A. Riazi, Jalal Soubhye, P. Antwerpen, 2018 .

Type 2 17-β hydroxysteroid dehydrogenase as a novel target for the treatment of osteoporosis.

Jalal Soubhye, P. Van Antwerpen, F. Dufrasne, 2015, Future medicinal chemistry.